• Bicara Therapeutics CFO Ivan Hyep sold 9,200 common shares on May 21 at a weighted average USD 20.42.
• He also exercised stock options for 9,200 shares at USD 3.79 on the same day.
• Hyep held 145,355 common shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-038248), on May 26, 2026, and is solely responsible for the information contained therein.